NL-OMON47765已完成不适用
18F-Flutemetamol PET/MRI for detection of plaque vulnerability in atherosclerosis - PET/MRI and plaque vulnerability: Flutemetamol
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Age 18 years and older (no maximum age)
- •Informed consent by signed informed consent form regarding this study
- •Either: Patients, who are scheduled for carotid endarterectomy (CEA)
- •Or: Patients who are not scheduled to undergo a CEA, but have experienced a
- •TIA/CVA/amaurosis fugax within the last 14 days and at least a 30% stenosis of
- •the symptomatic carotid artery as based on imaging.
排除标准
- •Severe cognitive impairment, neurological deficit or comorbidity causing the
- •study to be too high a burden for the patient or disrupting patient*s
- •co-operation with scan procedures.
- •Evident other causality for stroke (cardiac embolus, small vessel disease,
- •carotid dissection or thrombogenic diathesis).
- •Pregnant women and nursing mothers.
- •Contra-indications for MRI.
- •*Relative contra-indications for MRI-contrast agent: GFR
- •<30ml/min/1,73m2/Previous allergic reaction to MRI contrast agent.
- •Contra-indication Flutemetamol: Hypersensitivity to the active substance or to
- •any of the excipients, severe liver dysfunction
研究者
相似试验
撤回
不适用
18F-fluoride PET-scan as complementary diagnostic medium for patients with otosclerosis - A pilot studyfixation of the stapes1001399510027584otosclerosisNL-OMON36729Medisch Universitair Ziekenhuis Maastricht40
尚未招募
不适用
se of the PET/CT [18F]-Fluorocholine: Diagnostics and Follow-up of Hepatocellular Carcinomahepatocellular carcinomalivercancer1001981510019818NL-OMON36749Academisch Medisch Centrum100
进行中（未招募）
1 期
18F-fluoride PET for Early Non-invasive Assessment of Cortical Bone Formation - Non-invasive Assessment of Cortical Bone Formation - Version 1EUCTR2009-016523-61-GBKing’s College London30
尚未招募
不适用
se of a PET scan to quantify disease activity in patients with hearing loss due to otosclerosis.Onderwerp:- Keel-, neus- en oorheelkunde- Otosclerose (fenestraal en cochleolabyrinthair) - PET/CT-beeldvormingSubject:- Otorhinolaryngology- Otosclerosis (fenestral and cochlear)- PET/CT imagingNL-OMON21643INITIATOR: J.J. WatervalP. Debyelaan 25Postbus 58006202 AZ Maastricht(T) +31-(0)433876543(E) J.Waterval@gmail.com40
已完成
不适用
[18F]fluoro-PEG-folate PET/CT imaging in patients with epithelial ovarian cancerEpithelial ovarian cancer10033283NL-OMON52813eids Universitair Medisch Centrum15